Terms: = Pancreatic cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Treatment
23 results:
1. Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter study.
Man Q; Pang H; Liang Y; Chang S; Wang J; Gao S
Medicine (Baltimore); 2024 Mar; 103(10):e37440. PubMed ID: 38457597
[TBL] [Abstract] [Full Text] [Related]
2. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.
Kobayashi S; Nakachi K; Ikeda M; Konishi M; Ogawa G; Sugiura T; Yanagimoto H; Morinaga S; Wada H; Shimada K; Takahashi Y; Nakagohri T; Kamata K; Shimizu Y; Ajiki T; Hirano S; Gotohda N; Ueno M; Okusaka T; Furuse J
Eur J Surg Oncol; 2024 Feb; 50(2):107324. PubMed ID: 38157649
[TBL] [Abstract] [Full Text] [Related]
3. Increasing Systemic Immune-inflammation Index During treatment in Patients With Advanced pancreatic cancer is Associated With Poor Survival: A Retrospective, Multicenter, Cohort Study.
van 't Land FR; Aziz MH; Michiels N; Mieog JSD; Bonsing BA; Luelmo SAC; Homs MYV; Groot Koerkamp B; Papageorgiou G; van Eijck CHJ
Ann Surg; 2023 Dec; 278(6):1018-1023. PubMed ID: 37010512
[TBL] [Abstract] [Full Text] [Related]
4. Postoperative complications and short-term prognosis of laparoscopic pancreaticoduodenectomy vs. open pancreaticoduodenectomy for treating pancreatic ductal adenocarcinoma: a retrospective cohort study.
Zhang B; Xu Z; Gu W; Zhou J; Tang N; Zhang S; Chen C; Zhang Z
World J Surg Oncol; 2023 Jan; 21(1):26. PubMed ID: 36710324
[TBL] [Abstract] [Full Text] [Related]
5. Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; ; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; ; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ
Clin Cancer Res; 2022 Dec; 28(24):5383-5395. PubMed ID: 36222710
[TBL] [Abstract] [Full Text] [Related]
6. Initial Experience with Robotic Gastrectomy in Patients with Gastric cancer: An Assessment of Short-Term Surgical Outcomes.
Isobe T; Murakami N; Minami T; Tanaka Y; Kaku H; Umetani Y; Kizaki J; Aoyagi K; Kashihara M; Fujita F; Akagi Y
Kurume Med J; 2022 Nov; 67(2.3):77-82. PubMed ID: 36123025
[TBL] [Abstract] [Full Text] [Related]
7. Impact of the SARS-CoV-2 pandemic on pancreatic cancer: diagnosis and short-term survival.
Tejedor-Tejada J; Gómez-Díez C; Robles Gaitero S; Villar Caamaño A; Hermida Pérez B; Olmos JM; Álvarez Álvarez A; Tojo González R
Rev Esp Enferm Dig; 2022 Aug; 114(8):509-510. PubMed ID: 35297265
[TBL] [Abstract] [Full Text] [Related]
8. First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy.
Diamond JR; Boni V; Lim E; Nowakowski G; Cordoba R; Morillo D; Valencia R; Genvresse I; Merz C; Boix O; Frigault MM; Greer JM; Hamdy AM; Huang X; Izumi R; Wong H; Moreno V
Clin Cancer Res; 2022 Apr; 28(7):1285-1293. PubMed ID: 35046056
[TBL] [Abstract] [Full Text] [Related]
9. Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy.
Shen J; Qi W; Dai J; Leng S; Jiang K; Zhang Y; Ran S; Li C; Wen T
Chin Med J (Engl); 2021 Dec; 135(3):301-308. PubMed ID: 34958539
[TBL] [Abstract] [Full Text] [Related]
10. Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial.
Aramaki O; Takayama T; Moriguchi M; Sakamoto H; Yodono H; Kokudo N; Yamanaka N; Kawasaki S; Sasaki Y; Kubota K; Otsuji E; Tanaka S; Matsuyama Y; Fujii M;
Eur J Cancer; 2021 Nov; 157():373-382. PubMed ID: 34563992
[TBL] [Abstract] [Full Text] [Related]
11. Postoperative morbidity following pancreatic cancer surgery is significantly associated with worse overall patient survival; systematic review and meta-analysis.
Mintziras I; Wächter S; Manoharan J; Kanngiesser V; Maurer E; Bartsch DK
Surg Oncol; 2021 Sep; 38():101573. PubMed ID: 33857838
[TBL] [Abstract] [Full Text] [Related]
12. Association of treatment Inequity and Ancestry With pancreatic Ductal Adenocarcinoma Survival.
Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
[TBL] [Abstract] [Full Text] [Related]
13. Delaying surgery after preoperative biliary drainage does not increase surgical morbidity after pancreaticoduodenectomy.
Yang F; Jin C; Zou C; Di Y; Hao S; Huang H; Warshaw AL; Fu D
Surgery; 2019 Dec; 166(6):1004-1010. PubMed ID: 31466857
[TBL] [Abstract] [Full Text] [Related]
14. Nodal downstaging as a treatment goal for node-positive pancreatic cancer.
Portuondo JI; Massarweh NN; Zhang Q; Chai CY; Tran Cao HS
Surgery; 2019 Jun; 165(6):1144-1150. PubMed ID: 30745009
[TBL] [Abstract] [Full Text] [Related]
15. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract] [Full Text] [Related]
16. Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study.
Wang Q; Xia D; Bai W; Wang E; Sun J; Huang M; Mu W; Yin G; Li H; Zhao H; Li J; Zhang C; Zhu X; Wu J; Li J; Gong W; Li Z; Lin Z; Pan X; Shi H; Shao G; Liu J; Yang S; Zheng Y; Xu J; Song J; Wang W; Wang Z; Zhang Y; Ding R; Zhang H; Yu H; Zheng L; Gu W; You N; Wang G; Zhang S; Feng L; Liu L; Zhang P; Li X; Chen J; Xu T; Zhou W; Zeng H; Zhang Y; Huang W; Jiang W; Zhang W; Shao W; Li L; Niu J; Yuan J; Li X; Lv Y; Li K; Yin Z; Xia J; Fan D; Han G;
J Hepatol; 2019 May; 70(5):893-903. PubMed ID: 30660709
[TBL] [Abstract] [Full Text] [Related]
17. TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial).
Ioka T; Ueno M; Ueno H; Park JO; Chang HM; Sasahira N; Kanai M; Chung IJ; Ikeda M; Nakamori S; Mizuno N; Omuro Y; Yamaguchi T; Hara H; Sugimori K; Furuse J; Maguchi H; Furukawa M; Fukuzawa K; Kim JS; Yukisawa S; Takeuchi M; Okusaka T; Boku N; Hyodo I
Eur J Cancer; 2019 Jan; 106():78-88. PubMed ID: 30471651
[TBL] [Abstract] [Full Text] [Related]
18. Are Clinical Guidelines for the Management of Intraductal Papillary Mucinous Neoplasms Followed?: A Single-Center Analysis.
Tabrizian P; Berger Y; Pierobon ES; Aycart S; Argiriadi P; Fei K; Carrasco-Avino G; Labow DM; Sarpel U
Pancreas; 2017 Feb; 46(2):198-202. PubMed ID: 28060184
[TBL] [Abstract] [Full Text] [Related]
19. Assessing the Financial Burden Associated With treatment Options for Resectable pancreatic cancer.
Cerullo M; Gani F; Chen SY; Canner JK; Herman JM; Laheru D; Pawlik TM
Ann Surg; 2018 Mar; 267(3):544-551. PubMed ID: 27787294
[TBL] [Abstract] [Full Text] [Related]
20. CD44 Expression Level and Isoform Contributes to pancreatic cancer Cell Plasticity, Invasiveness, and Response to Therapy.
Zhao S; Chen C; Chang K; Karnad A; Jagirdar J; Kumar AP; Freeman JW
Clin Cancer Res; 2016 Nov; 22(22):5592-5604. PubMed ID: 27267855
[TBL] [Abstract] [Full Text] [Related]
[Next]
